Midostaurin (PKC412) for Locally Advanced Rectal Cancer
NCT01282502
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Adenocarcinoma of the Rectum
Interventions
DRUG:
Midostaurin
Sponsor
Massachusetts General Hospital